Loading clinical trials...
Loading clinical trials...
A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors
Conditions
Interventions
bleomycin sulfate
cisplatin
+4 more
Locations
24
United States
M. D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
Centre Paul Papin
Angers, France
Institut Bergonie
Bordeaux, France
C.H.U. de Brest
Brest, France
Centre Regional Francois Baclesse
Caen, France
CHU de Grenoble - Hopital de la Tronche
Grenoble, France
Start Date
November 26, 2003
Primary Completion Date
March 29, 2012
Completion Date
February 8, 2023
Last Updated
February 6, 2025
NCT07453082
NCT03067181
NCT05564026
NCT05670938
NCT04623658
NCT06191575
Lead Sponsor
UNICANCER
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions